【摘要】 通过DEA(数据包络分析方法)模型进行多投入多产出的效率分析,评价2010-2015年中国上市医药公司经营效率。分析发现:134个医药上市公司的总体效率呈下降趋势,分别体现为技术效率以及规模效率都呈下降趋势,不同类型的医药公司具有不同的变化特点。结论认为,中国各类医药公司应该积极提高公司的技术水平,创新生产模式,从而获得公司的核心竞争力;同时政府应该积极推动医药公司资源的综合利用,提高产业集聚的质量,优化中国医药产业结构。更多还原

【Abstract】 We use the DEA( Data Envelopment Analysis) model to analyze the efficiency of multi-input and multi-output and to evaluate the operating efficiency of Chinese pharmaceutical companies from 2010 to 2015. The result shows that the overall efficiency of 134 pharmaceutical companies is declining and that the technical efficiency and scale efficiency are decreasing,especially in biotechnology enterprises and traditional Chinese medicine enterprises. Hence,it is concluded that the Chinese government should actively promote the comprehensive utilization of resources of Chinese pharmaceutical enterprises,improve the quality of industrial agglomeration,and optimize the quality of pharmaceuticals in China’s pharmaceutical industry.更多还原